Michael Sela

Michael Sela (Hebrew: מיכאל סלע‎‎) (born 2 March 1924) is an Israeli immunologist of Polish Jewish origin. He is W. Garfield Weston Professor of Immunology at the Weizmann Institute of Science in Rehovot.[1]

Birth and academic career

Michael Sela was born as Mieczyslaw Solomonowicz in Tomaszów Mazowiecki, Poland, in 1924. Today, he is Professor in the Weizmann Institute's Immunology Department.

Research

Sela is known for his research in immunology, particularly for research on synthetic antigens, molecules that trigger the immune system to attack. These work of Sela have led to the discovery of the genetic control of the immune response, as well as to the design of vaccines based on synthetic molecules.

He was among the first who introduced the use of linear and branched synthetic polypeptides as antigens, and this brought about a better understanding of immunological phenomena.

For several decades, Sela have been interested in the possibility of fighting the autoimmune disease, experimental allergic encephalomyelitis (EAE) with synthetic analogs of the molecules in the myelin sheath of the brain which are capable of provoking the disease.

He is probably best known as the co-developer (with Ruth Arnon and Dvora Teitelbaum) of the multiple sclerosis drug copaxone.

Awards and honours

Sela has received several awards. Following are the major awards received by Sela.

See also

References

  1. ↑ Michael Sela at the Weizmann Institute of Science
  2. ↑ "Israel Prize recipients in 1959 (in Hebrew)". Israel Prize Official Site. Archived from the original on January 1, 1970.
  3. ↑ "Otto-Warburg-Medal". GBM. Retrieved 12 January 2014.
  4. ↑ The Wolf Prize in Medicine

External links

This article is issued from Wikipedia - version of the 7/12/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.